Member Info for jmfw

Apre 19:45 Think your sexually explicit invite is a little out of order on such a decorous board.

truer picture on here:
https://investing.thisismoney.co.uk/trades/AVCT/Avacta-Group.html

I'm still confused by the Holdings RNS. Altho CM LLC appear to have a significant holding in Angle, & now us, according to this ( & other 13f listings) they are not invested in any pharma/biotech coys https://gb.wallmine.com/fund/4dq/conifer-management-l-l-c
Can anyone explain? Please.

Thanks Phantom, that's reassuring. I was going by Conifer's latest 13F filing which doesn't include any Pharma/Biotech coy

Conifer not appear to be invested in any other biotech/pharma. Some retail, telecoms, building materials, cars, google, & some others. Strategic??? Certainly left-field for them . However, "Conifer Management is based out of New York. Conifer Management is a hedge fund with 5 clients ", so could have been instructed by a specific client.

Previously posted this, but think it ties in beautifully with our technology so worth repeating:

Adeptrix’ patented Bead-Assisted Mass Spectrometry (BAMS™) technology is currently being applied in drug discovery to aid understanding of disease onset, preclinical drug discovery and is well positioned as the next generation diagnostic readout. Unlike the existing DNA and RNA based assay platforms, BAMS™ measures proteins and their modifications – ultimately the drivers of disease and the critical targets for drug development.

“The BAMS™ assay platform is a disruptive technology, because it provides a simple workflow for targeted proteomics and will enable many more scientists to ask deeper questions of their biological assays,” said Dr. Jeffrey C. Silva, Director of Product Development at Adeptrix Corporation. “The assay technology couples the specificity of affinity capture with the speed and sensitivity of mass spectrometry detection to enable screening of ONE to THOUSANDS of proteins in a single experiment. BAMSTM is quite versatile and can be utilized to monitor any protein (or a panel of proteins) of interest.”

ICV & Venture Engineering Funds identify and invest in game-changing life science technologies.

Same for me - 'did not meet the criterea'. Didn't follow it up as I found, shortly after, the offer had been closed.

Is it possible that the testing may take longer &/or be slightly different due detached spike protein.
"Cytiva and Avacta will now work to develop rapid test strips for the detached spike protein and for the intact virus particle, aiming to have prototype devices in a few weeks."

Iceni interesting: https://www.genengnews.com/insights/iceni-diagnostics-hopes-for-home-use-coronavirus-test-this-autumn/
While the test is undergoing clinical assessment, Iceni Diagnostics is in parallel working to ensure that mass production can be rolled out once validation is completed. Product development manager Chris Liggett told GEN that the firm is “in discussions with two leading lateral flow device manufacturers who have the capacity and availability to support our launch plans for both the UK and overseas markets.”

Anyone know if the item dated 21 May on EKF's site is fresh news? It looks like it.
https://www.ekfdiagnostics.com/news.html

Think we owe a lot to that rns. All the subsequent coverage has brought attention to us (completely free). Almost certainly at least one positive rns will follow before the end of next week, otherwise we will have shot ourselves in the foot!
However, believe the management knows exactly what it's doing & is building expectation against which it (believes) it can deliver.

Any one know whether Cytiva or Avacta will break the news (hopefully good) we all await. Post midday for us, if Cytiva.

Also, just noticed this https://twitter.com/TheBHF/status/1262723738262540288
can only believe it's BP

https://www.ilctherapeutics.com/

Concur with raharh

To realise the (potential) true value in Avacta it wouldn't be the biggest surprise if the Company was split into two - Therateutics & Diagnostics, with one/both floated on Nasdaq.

Just noticed what appears to be a purchase at 3pm of 70k shares in US dollars.

is it for avct? https://mologic.co.uk/british-companies-mologic-and-biosure-partner-on-covid-19-antibody-self-test/

but is it also for ODX? https://mologic.co.uk/british-companies-mologic-and-biosure-partner-on-covid-19-antibody-self-test/

lombard have made a lot of money. they added to their holding on/before 14 april @ +/- 57p & have sold down at least 3 times since. value wise they are probably worth as much as the 6.82% they held prior 14 april, so they will probably hold the balance (which is for free)